FDAnews Drug Daily Bulletin

Exports, Imports and Warnings (Drug Wonks blog)
“Since the end of 2011 the FDA has sent 11 warning letters to companies in seven different countries that were exporting drugs to the U.S. after having let their required registration and listing expire,” blogger Peter Pitts writes. Since the heparin scandal in 2008, the FDA’s vigilance on foreign suppliers has sharpened. “And new provisions in the recently passed user fee legislation are designed to reduce the number of unregistered facilities — particularly for generic drugs” Pitts writes, adding, “But that was before sequestration.”